Elicera Therapeutics AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Rolf Ingvar Lennart Karlsson, was filed 11 Mar 2025.
Elicera Therapeutics AB: what insiders have been doing
This page follows insider dealings at Elicera Therapeutics AB as filed with Finansinspektionen, a company from the Health Care sector. Nothing new has been filed by managers of Elicera Therapeutics AB in twelve months, the latest record being from 12 March 2025.
Over the whole record (from 2021), the tally stands at 11 purchases and 3 sales.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleAnalyst consensus: bullish or bearish?
Analysts rate Elicera Therapeutics AB Strong Buy (bullish), based on 2 analysts. Average price target: SEK 7.25.
Financial data
as of FY 2025FY ended December 2025 · cache
- 43,211 shares@ SEK 1.850.042% mcap100.0% of flowInterimsaktieISIN SE0015382080FI:A003M442-1
- 21,700 shares@ SEK 1.850.021% mcap100.0% of flowInterimsaktieISIN SE0015382080FI:A003M484-1
- 18,000 shares@ SEK 0.50100.0% of flowOptionISIN SE0021626314FI:A003M381-1Canonical exit: 8 Jun 2025 (T+90)
- 280,000 shares@ SEK 0.9451.3% of flowAktieISIN SE0015382080FI:csv-a5a68ee0e2a857bde9f8
- 50,000 shares@ SEK 1.001.2% of flowAktieISIN SE0015382080FI:csv-25b20528b0356f67c84cCanonical exit: 24 Jul 2024 (T+90)
- 2,687,000 shares@ SEK 1.2886.9% of flowAktieISIN SE0015382080FI:csv-e3a9030e63df6127e55f
- 4,518 shares@ SEK 16.2054.6% of flowBTU (betald tecknad unit)ISIN SE0021626306FI:csv-c9f2a36fb0638977e9d1
- 3,100 shares@ SEK 16.2033.8% of flowBTU (betald tecknad unit)ISIN SE0021626306FI:csv-5e6f9e73fbca92d33dfc
- 21,700 shares@ SEK 16.209.0% of flowBTU (betald tecknad unit)ISIN SE0021626306FI:csv-546cf3d6d9a0d0051b89
- 64,500 shares@ SEK 0.01830.0% of flowTeckningsrätt/UniträttISIN SE0021626298FI:csv-c5f34a26288df3a904dcCanonical exit: 26 May 2024 (T+90)
- 31,000 shares@ SEK 0.00510.0% of flowTeckningsrätt/UniträttISIN SE0021626298FI:csv-5cf1258f715311d396f4Canonical exit: 2 Jun 2024 (T+90)
- 500,000 shares@ SEK 0.00240.0% of flowTeckningsrätt/UniträttISIN SE0021626298FI:csv-eee4290288ab2ac113d3
- 1,687,000 shares@ SEK 0.00160.1% of flowTeckningsrätt/UniträttISIN SE0021626298FI:csv-f205cd4a084eaeb106ee
- 3,100 shares@ SEK 16.20100.0% of flowBTU (betald tecknad unit)ISIN SE0021626306FI:csv-275cb9af8cef71888fd0
- 10,000 shares@ SEK 16.2054.3% of flowBTU (betald tecknad unit)ISIN SE0021626306FI:csv-122f1ae3c565878ce9b5
- 4,300 shares@ SEK 16.2023.4% of flowBTU (betald tecknad unit)ISIN SE0021626306FI:csv-67aae51036a040b00b9c
- 6,173 shares@ SEK 16.2020.4% of flowBTU (betald tecknad unit)ISIN SE0015382080FI:csv-3b73ffdc821797a5298e
- 12,345 shares@ SEK 16.2077.7% of flowBTU (betald tecknad unit)ISIN SE0021626306FI:csv-0022345047b45d987cf5
- 4,800 shares@ SEK 16.2039.2% of flowBTU (betald tecknad unit)ISIN SE0021626306FI:csv-5688932e2b4fe70b0b80
- 2,583,333 shares0AktieISIN SE0015382080FI:csv-d3c1ba7db730294b9544
- 2,583,333 shares0AktieISIN SE0015382080FI:csv-da292808b8c1076455aa
- 2,583,334 shares0AktieISIN SE0015382080FI:csv-62a225dc8be56bbe950c
- 12,100 shares@ SEK 4.3011.7% of flowAktieISIN SE0015382080FI:csv-f7f3271e35f9c478e057Canonical exit: 3 Oct 2021 (T+90)
- 12,791 shares@ SEK 4.3045.4% of flowAktieISIN SE0015382080FI:csv-18d24e8e936233d72013Canonical exit: 3 Oct 2021 (T+90)
- 14,000 shares@ SEK 4.3022.3% of flowAktieISIN SE0015382080FI:csv-359c24db5e4e74a64adfCanonical exit: 3 Oct 2021 (T+90)
25 of 31 declarations
About Elicera Therapeutics AB
Elicera Therapeutics AB is a biopharmaceutical company focused on developing innovative therapies based on advanced technologies. It specializes in the treatment of cancer and other serious diseases.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
